“USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS”, Mediterr J Hematol Infect Dis, vol. 2, no. 1, p. e2010003, Mar. 2010, doi: 10.4084/mjhid.2010.003.